Cilnidipine ( DrugBank: Cilnidipine )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
67多発性嚢胞腎2

67. 多発性嚢胞腎


臨床試験数 : 216 薬物数 : 219 - (DrugBank : 50) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 150
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00890279
(ClinicalTrials.gov)
July 200928/4/2009Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)Phase II Study for the Second-Line Treatment of Hypertension in Patients With Autosomal Dominant Polycystic Kidney Disease; ACEI vs. CCBKidney, Polycystic, Autosomal DominantDrug: Cilnidipine;Drug: ImidaprilMinistry of Health, Labour and Welfare, JapanNULLRecruiting20 Years60 YearsBoth160Phase 2Japan
2NCT00541853
(ClinicalTrials.gov)
December 20079/10/2007CCB Safety Study in Treatment of Hypertension of ADPKDComparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertensive ADPKD PatientsKidney, Polycystic, Autosomal DominantDrug: Candesartan;Drug: Candesartan and Cilnidipine;Drug: Candesartan plus non-CCB agentsKyorin UniversityMinistry of Health, Labour and Welfare, JapanNot yet recruiting20 Years60 YearsBoth150Phase 4Japan